Mid-Year Report

FOLEY HOAG LLP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent Reform, S 1145, HR 1908

LobbyistCovered position, as disclosed
THOMAS GRISSOM N/A
PAUL KIM N/A
DAVID MOHLER N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1908 (110th)

Health Issues HCR

Pharmaceutical Legislation Food and Drug Administration, S 1082, HR 2900 Follow-on Biologics, S 1695

LobbyistCovered position, as disclosed
THOMAS GRISSOM N/A
PAUL KIM N/A
DAVID MOHLER N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2900 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.